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Common variable immunodeﬁciency (CVID) is a heterogeneous disorder with susceptibility to infections, autoimmune
manifestations, and cancer. To our knowledge, CIVD with T-cell lymphoma mimicking juvenile systemic lupus erythematosus
(JSLE) was not described in the literature, and one case was reported herein. An 8-year-old female was admitted in our Pediatric
Immunology Unit with a clinical history of hypogammaglobulinemia, recurrent upper respiratory infections, and pneumonias.
She had a marked decrease of three serum immunoglobulin isotypes, and the diagnosis of CVID was established. At the age of 17
years, she presented with oral ulceration, nonerosive arthritis, nephritis, serositis, cytopenia, positive antiphospholipid antibodies,
and positive antinuclear antibody fulﬁlling the American College of Rheumatology (ACR) criteria for SLE. She was treated
with intravenous methylprednisolone for three consecutive days, and intravenous immunoglobulin, and maintenance therapy of
chloroquine, azathioprine and prednisone 40mg/day. Two months later, she died of septic shock secondary to acute pneumonia.
The necropsy showed hepatosplenic T-cell lymphoma with diﬀuse involvement of bone marrow, spleen, liver, and lungs. The
lymphoma cells were positive for CD3 immunostaining and negative for CD20 and lysozyme. In conclusion, the association of
CVID and hepatosplenic T-cell lymphoma may simulate JSLE diagnosis.
1.Introduction
The juvenile form of systemic lupus erythematosus (SLE) is
a rare autoimmune disorder that may aﬀect multiple organs
and systems [1]. Of note, some primary immunodeﬁciencies
(PIDs) are frequently associated to early-onset SLE or lupus
manifestations, such as the deﬁciencies of the ﬁrst com-
ponents of the classical complement pathway and selective
IgA deﬁciency [2]. On the other hand, PIDs with severe
antibody synthesis deﬁciency, such as agammaglobulinemia
and common variable immunodeﬁciency (CVID), have been
rarely associated to SLE development [1].
CVID is a heterogeneous disorder with susceptibility to
infections, autoimmune manifestations, and cancer [3]a n d
has been classiﬁed as a predominant antibody deﬁciency
according to the International Union of Immunological
Societies (IUIS) updated classiﬁcation [4]. This PID is char-
acterized by a marked decrease of two serum immunoglob-
ulin isotypes, usually IgG and IgM and/or IgA, over two
standard deviations below mean values for age, in addition
to impaired ability to speciﬁc antibody production after
vaccination or exposure to a known infectious agent [3].
Autoimmune manifestations have been described in up
to 20% of CVID patients [3]. The most common autoim-
mune complications reported are the cytopenias, especially
immune thrombocytopenic purpura, and autoimmune hep-
atitis [3]. Additionally, systemic lupus erythematosus (SLE)
wasrarelyreportedinCVIDpatients[5],generallydiagnosed
during the disease followup.2 Clinical and Developmental Immunology
Furthermore, CVID patients have 2–8% of non-
Hodgkins lymphoma, especially from B-cell origin [3].
However, to our knowledge, CVID with T-cell lymphoma
mimicking juvenile SLE (JSLE) was not described in the
literature, and one case was reported herein.
2.CaseReport
An 8-year-old female was admitted to the Pediatric
Immunology Unit with a clinical history of recurrent upper
respiratory infections, pneumonias, and hypogammaglobu-
linemia. She presented with the ﬁrst severe infection when
she was 6 months old, needing hospitalization in intensive
care unit (ICU). At 5 and 7 years old, she had two
pneumonias with pleural eﬀusion. On admission, aged 8
years old, physical examination detected weight and height
on the 25th percentile. Laboratory exams demonstrated
hemoglobin 12.5g/L, hematocrit 40.1%, white blood cell
count 6500cells/mm3, platelets 211,000/mm3,a n dr e d u c e d
serum levels of IgG 268–497mg/dL (normal range 952–
1538mg/dL), IgA <6mg/dL (normal 111–335), and IgM
55–122mg/dL (normal 59–151). Speciﬁc IgG antibodies for
measlesandrubellawerenegativedespiteappropriateimmu-
nization. Lymphocyte immunophenotyping showed CD3+
2085cells/mm3 (normal 6052460), CD4+ 936cells/mm3
(normal 493–1666), CD8+ 937cells/mm3 (normal 224–
1112), CD16+/56+ 233cells/mm3 (normal 73–654), and
CD19+ 69cells/mm3 (normal 72–520). Further ﬂow cytom-
etry tests showed CD19+ cells ranging from 0 to 4%.
Therefore, CVID was diagnosed according to IUIS criteria
(decrease of at least two serum immunoglobulin isotypes
and negative speciﬁc antibody production after vaccina-
tion) [4], and prophylactic antibiotics and intravenous
immunoglobulin (IVIG) were started. Antinuclear antibody
(ANA) and rheumatoid factor (RF) were negative at that
moment. The treatment resulted in the maintenance of
IgG ≥600mg/dL and in a reduced frequency of infec-
tious episodes. However, during the followup, she was
hospitalized eight times due to septic shock (n = 3),
pneumonia with pleural eﬀusion (n = 2), otomastoiditis
(n = 1), acute cytomegalovirus infection (n = 1), and
urinary tract infection (n = 1). At 12 years old, she
developed pancytopenia [hemoglobin 10.2g/L, hematocrit
34.2%, white blood cell count 3,790/mm
3 (39% neutrophils,
54% lymphocytes, 2% eosinophils, and 5% monocytes), and
platelets 108,000/mm
3] associated to hepatosplenomegaly.
Reticulocyte count was 1.2%, and lactate dehydrogenase
(LDH) was 164mg/dL (normal 117–213). Bone marrow
aspiration was performed twice and showed hyperplasia of
erythrocyte and hypoplasia of granulocyte series. At that
moment, autoantibodies were not detected, such as: ANA,
RF, antidouble-stranded DNA (anti-dsDNA), anti-Sm, anti-
RNP, anti-Ro, anti-La, anti-P ribosomal, anticardiolipin IgG
and IgM, lupus anticoagulant, anti-Scl70, anti-Jo1, anti-
insulin, antineutrophil cytoplasmic (ANCA), antiglutamic
acid decarboxylase (anti-GAD), antiinsulin, antithyroglobu-
lin, antiperoxidase, antiparietal cell, antiendomysium, anti-
smoothmuscle,andanti-liver-kidneymicrosomeantibodies.
At the age of 17 years, the patient presented with fever, oral
ulcers, alopecia, arthritis of wrists and elbows, headache,
and cough and was hospitalized. She developed pleural and
large pericardial eﬀusion and was admitted to ICU. Labo-
ratory exams revealed hemoglobin 7.9g/L, hematocrit 22%,




(normal 79152), and C4 4mg/dL (16–38). Polymerase chain
reactions (PCR) for Epstein-Barr virus and blood and
urine cultures were negative. The following autoantibodies
were observed: ANA (1:320, dense ﬁne speckled pattern),
anticardiolipin IgM (100MPL), RF, and lupus anticoagulant.
At that moment, she fulﬁlled the American College of
Rheumatology (ACR) [6] criteria for SLE. Additionally, she
also had hepatosplenomegaly, aspartate aminotransferase
(AST) 58IU/l (normal 0–20IU/l), alanine aminotransferase
(ALT) 111IU/l (normal 6–20 IU/L), triglycerides 456mg/dL
(normal <130mg/dL), ferritin 6034ng/mL (36–92ng/mL),
and LDH 791mg/dL. She fulﬁlled the preliminary criteria
for macrophage activation syndrome in pediatric SLE [7]
and was treated with intravenous methylprednisolone for
three consecutive days and IVIG (2g/kg/dose) and, after
chloroquine (250mg/day), azathioprine (100mg/day) and
prednisone 40mg/day. At that moment, bone marrow
aspiration evidenced hypoplasia in all cell lineages without
neoplastic cells or hemophagocytosis. Renal biopsy showed
chronic tubulointerstitial nephritis and focal acute tubular
necrosiswithoutglomerularinjuryandnegativeimmunoﬂu-
orescence for IgA, IgG, IgM, C1q, C3, and ﬁbrinogen,
and liver biopsy showed drug-induced hepatitis without
neoplastic cells. Despite treatment, two months later, she
died of septic shock secondary to acute pneumonia. Remark-
ably, the necropsy showed hepatosplenic T-cell lymphoma
(HSTL) with diﬀuse involvement of bone marrow, spleen,
liver, and lungs. The lymphoma cells were positive for CD3
immunostaining and negative for CD20 and lysozyme.
3. Discussion
Lymphomas, especially from B-cell origin, have been de-
scribedasassociatedto2–8%ofCIVDpatients[3].However,
to our knowledge, this was the ﬁrst case reported in the
literature that described CVID with HSTL. Moreover, the
clinical and laboratorial features mimicked JSLE.
Peripheral T-cell lymphomas are rare neoplasms. Two
diﬀerent subtypes are known: HSTL and primary cutaneous
gammadelta T-cell lymphoma. Of note, HSTL is an extran-
odal lymphoma characterized by intrasinusoidal inﬁltration
of the bone marrow, liver, and spleen [8], as observed in
our patient. This entity has a rapidly and acute progressive
course, with pancytopenia and lung involvement and with-
out signiﬁcant lymphadenopathy, as also evidenced herein
[9]. This cancer commonly aﬀects male adolescents and
young adults [9] and may occur in patients under immune
system suppression [8], particularly long-term immuno-
suppressive therapy for solid-organ transplantation [9].
Lymphocyteimmunophenotypingisimportantfordeﬁnitive
diagnosis, especially expression of CD38.Clinical and Developmental Immunology 3
Importantly, CVID patients may present non-Hodgkin s
lymphoma generally in 6th and 7th decades and rarely in
pediatric population. The most frequent subtype of this
neoplasm is B cell without EBV infection [3]. Our female
patient had a T-cell lymphoma in the second decade of life.
In addition, the patient described herein had JSLE clin-
ical manifestations eleven years after CVID diagnosis. These
ﬁndings contrast with the few case reports on the association
between CVID and SLE thatshowed this primary immunod-
eﬁciency occurred during SLE followup. Fern´ andez-Castro
et al. [5] described two cases and reviewed the literature
regarding SLE and CVID association. In all the 18 cases
reported in the literature, CVID diagnosis was established
one to 22 years after SLE diagnosis. In all these cases, hy-
pogammaglobulinemia probably occurred as a complication
of the immunosuppressive therapy [5]. To our knowledge,
there is no case report of SLE after CVID or X-linked agam-
maglobulinemia diagnosis, and the autoantibody proﬁle in
thisgroupofpatientsisunknown.Furthermore,itisunusual
to see high titers of autoantibodies, as observed herein, in
CVID-related autoimmunity [1].
Ourpatienthad7ofthe11ACRclassiﬁcation28oflupus
criteria (oral ulceration, nonerosive arthritis, proteinuria,
serositis, hematologic abnormalities, positive antiphospho-
lipid antibodies, and positive ANA) [6] and hypocomple-
mentemia. Interestingly, the sensitivity and speciﬁcity of
ACR 1982 criteria for pediatric lupus were described as 96%
and 100%, respectively [10]. Despite this aspect, infectious
diseases and malignancies should be always considered as
diﬀerential diagnoses in pediatric lupus. Moreover, nephri-
tis is frequent in pediatric lupus population, and renal
biopsy did not show speciﬁc lupus nephritis ﬁndings with
a surprisingly negative immunoﬂuorescence in our case,
indicating that the proteinuria was not related to lupus.
The other clinical and laboratory features presented by the
patient, including ANA and antiphospholipid antibodies,
and initially attributed to lupus are nonspeciﬁc and could
be related to neoplasm diseases. In addition, our patient
did not show speciﬁc lupus autoantibodies (anti-dsDNA,
anti-Sm, and anti-P ribosomal). Therefore, she probably
had a lymphoma that mimicked lupus in a short period
of time and not a neoplasm that complicated a preceding
autoimmune disease. In fact, previously to the necropsy,
various pediatric specialists worked up for this patient, and
no malignancies were observed in the biopsies evaluated by
expert pathologists of our teaching university hospital.
Lupus mimicking lymphoma in adult population was
rarely described. Subcutaneous panniculitis-like T-cell lym-
phoma simulating a lupus erythematosus panniculitis with
systemic manifestations was reported in one 29-year-old
woman [11]. In contrast, JSLE with nephrotic syndrome and
mediastinal lymphadenopathy mimicking lymphoma was
described in one female adolescent [12].
Despite our patient had the preliminary criteria for
macrophageactivationsyndromewithhyperferritinemia[7],
these laboratory and clinical alterations are not speciﬁc
for autoimmune diseases and can be found in lymphoma
patients and infections [13].
Inconclusion,theassociationofCVIDandhepatosplenic
T-cell lymphoma with diﬀuse involvement of bone marrow,
spleen, liver, and lungs may simulate JSLE diagnosis.
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